In a word, LINC00460 promoted the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis, which provides a theoretical basis on PTC markers and potential therapeutic targets. This evidence concerns the gene RAF1 and thyroid gland papillary carcinoma.